HOME >> BIOLOGY >> NEWS
Leaders in sickle cell research meet in Cincinnati

CINCINNATI The Cincinnati Comprehensive Sickle Cell Center at Cincinnati Children's Hospital Medical Center will host the 28th annual meeting of the National Sickle Cell Disease Program from April 10 to 13 at the Northern Kentucky Convention Center in Covington.

World leaders in sickle cell research will present new research findings at the meeting. Some 200 presentations on topics ranging from complications of having sickle cell disease (pain, sleep disorders, stroke, neurological functioning, pulmonary hypertension) to the challenges of treating sickle disease in Africa will be presented.

Also on April 10, Cincinnati Children's and the Sickle Cell Awareness Group of Greater Cincinnati will host a community and family forum, "Sickle Cell: Beyond the Basics," from 12:30 to 6 p.m. at the Cincinnati Marriott at RiverCenter in Covington. The public forum is for families with sickle cell disease and the sickle cell trait, advocates and others interested in learning more about the disease. (Attendees must register in advance by April 1 by calling 513-281-4450.)

Sickle cell disease affects approximately 72,000 Americans, most of who are of African, Mediterranean and Middle Eastern descent. The disease disproportionately affects African Americans one in every 400 as compared to one in every 1,000 to 1,400 Hispanics.

Researchers are making strides in improving treatments for people with sickle cell disease and in developing a cure for the disease, according to Clinton Joiner, M.D., Ph.D., director of the Cincinnati Comprehensive Sickle Cell Center at Cincinnati Children's.

"The meeting, held four of every five years since 1972, represents a major national and international forum for researchers in sickle cell disease. It has become an important venue for basic science investigators, clinicians, service providers and advocacy groups to interact and collaborate with one another," he said.

Sickle cell disease is a genetic
'"/>

Contact: Amy Reyes
amy.reyes@cchmc.org
513-636-9684
Cincinnati Children's Hospital Medical Center
21-Mar-2005


Page: 1 2

Related biology news :

1. Conservation Leadership Program announces 2007 awardees
2. Scientific American names UCSB professor, alumna to list of Top 50 in Technological Leadership
3. Public Leadership in Neurology Award honors Cuba Gooding, Jr., for multiple sclerosis awareness
4. Eighteen researchers selected as 2006 Aldo Leopold Leadership Fellows
5. Workshop: Canadas Leadership in International Innovation
6. Ossur congratulates Hugh Herr on Popular Mechanics 2005 Breakthrough Leadership Award
7. HO-1 in sickle cell disease: friend or foe?
8. Discovery promises simpler therapy for sickle cell disease
9. UNC scientists identify sticky protein in sickle cell red blood cells
10. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
11. Saudi Arabias KAUST names WHOI first research partner

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Leaders sickle cell research meet Cincinnati

(Date:6/23/2015)... 2015 Research and ... the "Body-Worn Temperature Sensors Market - Global ... 2014 - 2020" report to their offering. ... the global body-worn temperature sensors market. The global ... the basis of types, care setting, patient demographic, ...
(Date:6/23/2015)... Fla. , June 23, 2015 /PRNewswire/ ... management and authentication solutions, today announced enhanced functionality ... multi-factor authentication solution.  The enhancements build on ... of the DigitalPersona Altus platform and provide ... compatibility. In today,s environment of ...
(Date:6/18/2015)... , June 18, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market announces that ... featured segment on "Money on the Mark", scheduled to air ... June 20 th . The ... be from 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO ...
Breaking Biology News(10 mins):Body-Worn Temperature Sensors Market - Global Industry Analysis 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
(Date:7/1/2015)... N.C. and PARIS ... firm AgBiome, and Genective, key developer of biotech ... the discovery of new generations of insect control ... insect control to counter the realities of advancing ... Genective, aligning AgBiome,s unique insect control technology with ...
(Date:7/1/2015)... ... 01, 2015 , ... The next-generation sequencing (NGS) clinical market is poised for ... diagnostics industry. BCC Research reveals in its new report that the market drivers of ... a growing need for better diagnostics as part of a molecular diagnostics trend. , ...
(Date:7/1/2015)... , July 1, 2015   Neuraltus Pharmaceuticals, ... development of groundbreaking drugs to treat neurodegenerative diseases ... that Robert G. Miller , M.D., Director of ... Health,s California Pacific Medical Center in San Francisco, has ... for $1.5 million to help fund a Phase ...
(Date:7/1/2015)... July 1, 2015 Isagenix International, a leading ... three Gold, three Silver, and three Bronze Stevie® Awards ... in Chicago this month.The ... business awards program in the U.S. ... strength in developing leaders, cultivating talent, creating a unified ...
Breaking Biology Technology:AgBiome and Genective collaborate to create novel insect-resistant crops 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Isagenix Earns Nine American Business Awards 2Isagenix Earns Nine American Business Awards 3
Cached News: